Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07305116 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

StatusRecruiting
PhasePhase 1
Started2025-12-01
View on ClinicalTrials.gov ↗

Amendment history

2026-01-31
minor
Study Status v1
Start dateestimated 2025-12→confirmed 2025-12-01
2025-12-12
minor
Original filing
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated autoimmune disease.
Trial Details
NCT Number NCT07305116
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Conditions Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN), Systemic Sclerosis (SSc), ANCA Associated Systemic Vasculitis
Enrollment 15 participants
Start Date 2025-12-01
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-03